EVG Evgen Pharma Plc

RNS Number:3430R
Evolution Group PLC
15 September 2005

                              Evolution Group Plc
                                        
                  Disclosure of Directors' Interest in Shares
                                        
                                        
For immediate release                                          15 September 2005

                              Evolution Group Plc

The Evolution Group Plc (the "Company") has today received notification from
Evolution EBT Limited as Trustee of The Evolution Group Plc Employees' Share
Trust ("the Trust") (a discretionary trust of which all employees of The
Evolution Group Plc and its subsidiaries are beneficiaries), that on 15
September 2005, 33,186 Ordinary 1p Shares ("Shares") were either transferred to,
or sold on behalf of, employees who had exercised options over Shares held in
the Trust.

None of the Shares referred to above was transferred to or sold on behalf of any
of the executive directors (the "Directors") of the Company.  However, each of
the Directors is a member of the class of discretionary beneficiaries of the
Trust and is consequently taken to have an interest in all the Shares held in
the Trust.  As a consequence of the vesting of the aforementioned Shares in
employees other than the Directors, the Directors have ceased to be interested
in those Shares.

The Trust now holds a total of 7,242,621 shares representing approximately 3.26%
of the Company's issued share capital.

For more information please contact:

The Evolution Group Plc
Graeme Dell, Finance Director           020 7071 4300






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSGUUQCBUPAGQA

Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Lug 2023 a Lug 2024